Article
Statistical models to capture the association between progression-free and overall survival in oncology trials
2020-01-01
Abstract excerpt
In oncology trials, different clinical endpoints can be measured. For the survival analysis of patients, the most traditional primary endpoint is overall survival (OS), which is defined as the time from study entry to death from any cause. Besides, progression-free related measurements such as progression-free survival (PFS) might be also considered. For assessing the performance of therapies, OS is the most relia...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 50b44679-c13f-5aea-98c8-ef44b5ce976c
- DOI
- 10.17635/lancaster/thesis/989
